Development and validation of a peripheral cell ratio and lactate score for differentiating status epilepticus from prolonged psychogenic nonepileptic seizures.
PNES
lactate
lymphocyte
monocyte
neutrophil
seizures
Journal
Epilepsia open
ISSN: 2470-9239
Titre abrégé: Epilepsia Open
Pays: United States
ID NLM: 101692036
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
07
06
2023
accepted:
25
08
2023
medline:
4
12
2023
pubmed:
29
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
Differentiating status epilepticus (SE) from prolonged psychogenic nonepileptic seizures (pPNES) can be difficult clinically. We aimed to define the utility of peripheral cell counts, cell ratios, and lactate levels in distinguishing SE from pPNES. Retrospective two-center study investigating the sensitivity and specificity of acute (≤12 h of event offset) peripheral cell counts, cell ratios (neutrophil-lymphocyte ratio, neutrophil-monocyte ratio, monocyte-lymphocyte ratio, platelet-lymphocyte ratio, systemic immune-inflammatory index [SII], systemic inflammatory response index [SIRI]), and lactate levels in differentiating SE from pPNES. Patients were identified from two tertiary hospitals, with one forming the development cohort and the other the validation cohort. Using generalized additive models to generate biomarker vs time curves, optimal blood collection times were defined for set parameters. Three diagnostic scores combining neutrophil count, SII, or SIRI with lactate levels were developed and validated in separate cohorts. For the development cohort, 1262 seizure-like events were reviewed and 79 SE and 44 pPNES events were included. For the validation cohort, 241 events were reviewed and 20 SE and 11 pPNES events were included. Individually, the biomarkers generally had low sensitivity and reasonable specificity for differentiating SE from pPNES, with the neutrophil count, SIRI, and SII performing best with sensitivities of 0.65-0.84, specificities of 0.64-0.89, and ROC AUCs of 0.78-0.79. Lactate levels peaked at 60 min, while cell counts and ratios peaked after 240 min. Combining early peaking lactate levels and later peaking neutrophil count, SIRI or SII resulted in three scores that improved predictive potential with sensitivities of between 0.75 and 0.79, specificities between 0.93 and 1.00, and ROC AUCs of 0.89-0.91. Lactate levels peak early post-SE, whereas cell counts and ratios do so later. The differing post-event time profiles of lactate levels vs neutrophil count, SIRI, and SII allow incorporation into three separate scores which can assist in differentiating SE from pPNES.
Identifiants
pubmed: 37641168
doi: 10.1002/epi4.12822
pmc: PMC10690667
doi:
Substances chimiques
Lactic Acid
33X04XA5AT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1460-1473Informations de copyright
© 2023 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):1987-92
pubmed: 26858400
Epilepsia. 2021 Feb;62(2):408-415
pubmed: 33417237
Int J Neurosci. 2017 May;127(5):417-420
pubmed: 27161531
J Neurol. 2018 Sep;265(9):2106-2113
pubmed: 29987588
Front Immunol. 2022 Dec 15;13:1090305
pubmed: 36591305
J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1341-1345
pubmed: 34362852
Epilepsy Behav. 2019 Jan;90:119-121
pubmed: 30530132
Intern Emerg Med. 2018 Aug;13(5):749-755
pubmed: 28900842
Seizure. 1998 Oct;7(5):403-6
pubmed: 9808117
Stroke. 2017 Jul;48(7):2007-2012
pubmed: 28626052
Epilepsia. 2015 Oct;56(10):1515-23
pubmed: 26336950
J Clin Lab Anal. 2021 Sep;35(9):e23935
pubmed: 34390017
J Neurol. 2003 Nov;250(11):1355-62
pubmed: 14648153
Int J Lab Hematol. 2021 Oct;43(5):948-958
pubmed: 33586915
Int J Neurosci. 2020 Nov;130(11):1095-1100
pubmed: 31983256
Epilepsy Behav. 2021 Mar;116:107736
pubmed: 33493811
Epilepsy Behav. 2017 Oct;75:13-17
pubmed: 28806632
J Autoimmun. 2019 Jan;96:24-34
pubmed: 30595145
Acta Neurol Scand. 2021 Mar;143(3):290-297
pubmed: 33091148
Seizure. 2019 Dec 31;76:17-21
pubmed: 31958705
BMC Neurol. 2023 Feb 10;23(1):64
pubmed: 36765289
Clin Cancer Res. 2014 Dec 1;20(23):6212-22
pubmed: 25271081
Epilepsia. 2019 Feb;60(2):349-357
pubmed: 30577087
Mov Disord. 2023 May;38(5):880-885
pubmed: 36811296
Seizure. 2020 Dec;83:17-20
pubmed: 33075672
Epilepsia. 2004 Aug;45(8):928-32
pubmed: 15270758
Epilepsia. 2021 Oct;62(10):2416-2425
pubmed: 34396517
Acta Neurol Scand. 2010 Sep;122(3):189-95
pubmed: 20003086
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Neurology. 2020 Oct 20;95(16):e2280-e2285
pubmed: 32943479
QJM. 1999 Jan;92(1):15-23
pubmed: 10209668
Seizure. 2016 Aug;40:71-5
pubmed: 27367837
Epilepsia Open. 2023 Dec;8(4):1460-1473
pubmed: 37641168
Cancer. 2016 Jul 15;122(14):2158-67
pubmed: 27152949
Epilepsy Res. 2020 May;162:106301
pubmed: 32126476
Seizure. 2009 Oct;18(8):543-53
pubmed: 19682927
Exp Neurol. 2008 Jun;211(2):370-7
pubmed: 18387608